TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma

BACKGROUND: Recent studies indicated that T cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) and cluster of differentiation 47 (CD47) have emerged as new potential immunotherapy targets. However, the roles of TIGIT and CD47 in lung squamous cell carcinoma (LUSC) have not been fully i...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yue, Qiu, Bin, Tan, Fengwei, Xu, Jiachen, Bie, Fenglong, He, Huayu, Liu, Lei, Tian, He, Bai, Guangyu, Zhou, Bolun, Li, Yuan, Huai, Qilin, Yang, Zhenlin, Gao, Shugeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284170/
https://www.ncbi.nlm.nih.gov/pubmed/35611464
http://dx.doi.org/10.1111/1759-7714.14478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284170/
https://www.ncbi.nlm.nih.gov/pubmed/35611464
http://dx.doi.org/10.1111/1759-7714.14478

Ejemplares similares